Breakthrough Cardiac Study Reveals Long-Term Impact on Post-Transplant Survival: A 2-Year Clinical Investigation Advancing Heart Preservation

Paragonix Technologies, Inc., a pioneer in organ transplant technologies and services, announces the annual release of the latest GUARDIAN-Heart Clinical R...

April 14, 2024 | Sunday | Reports
Merck Announces Positive Data on V116, a Promising Pneumococcal Vaccine for Adults

    The trials demonstrated V116's effectiveness in generating immune responses across all 21 serotypes covered by the vaccine in diverse adult...

March 20, 2024 | Wednesday | News
Labcorp's Latest Studies at SGO Meeting Herald New Era in Ovarian Cancer Biomarker Testing

In an effort to bridge testing gaps and facilitate targeted therapies for EOC patients, Labcorp conducted two seminal studies, illustrating the profound im...

March 18, 2024 | Monday | News
Sanofi's Amlitelimab Shows Long-Term Efficacy in Atopic Dermatitis Treatment, Shaping Future Therapeutic Strategies

  New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis Late-breaking dat...

March 11, 2024 | Monday | News
Catalent Publishes Fifth Annual Corporate Responsibility Report, Demonstrating Commitment to Sustainability and Social Impact

    One of the notable achievements in fiscal 2023 was Catalent's robust efforts to mitigate its environmental impact and combat climate ...

March 08, 2024 | Friday | News
Special Spotlight Report: GSK's COiMMUNITY Initiative Boosts Adult Vaccination Rates

  Rob Truckenmiller, Senior Vice President, Head of US Vaccines, GSK, emphasized the importance of collaborative efforts and fi...

March 08, 2024 | Friday | Reports
23andMe Releases New Genetic Reports on Breast, Colorectal, and Prostate Cancer Risk for Members

23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, released three new genetic reports for 23andMe+ members on breast...

March 06, 2024 | Wednesday | Reports
Catalent's Meteoric Rise as Novo Holdings Makes Groundbreaking Acquisition

In a landmark move within the life sciences sector, Novo Holdings has announced its acquisition of Catalent, Inc. in an all-cash transaction valued at $16....

February 08, 2024 | Thursday | News
Biopharma M&A outlook for 2024

Biopharma M&A in 2023 Biopharma M&A activity has witnessed a decisive rebound in 2023, with aggregate deal value up by 79% vs. 2022 to reach ~$152...

January 16, 2024 | Tuesday | News
Setting Sail in 2024: BioPharma Boardroom's Strategic Compass

As we stand on the precipice of 2024, the life sciences industry continues its dynamic evolution, propelled by groundbreaking discoveries, technological ad...

January 01, 2024 | Monday | News
BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients

71% intracranial objective response rate (iORR) in BriaCell patients with Central Nervous System (CNS) metastases support clinical efficacy of Bria-IMT&t...

January 01, 2024 | Monday | News
Can we crack this cancer's immune response?

More than 90% of pancreatic cancer cases are attributed to an aggressive, deadly form of the disease called pancreatic ductal adenocarcinoma, or PDAC. Rese...

November 30, 2023 | Thursday | Reports
Junshi Biosciences' VV116 COVID-19 Treatment Hits Lancet Infectious Diseases in Phase 3 Study Results

The paper presents final analysis results from a multicenter, double-blind, phase 3, randomized controlled study (NCT05582629) evaluating the efficacy and ...

November 24, 2023 | Friday | News
UK falls to third place in global Health Inclusivity Index

More than three in five (63%) people in the UK experience barriers to health inclusion People in UK, Canada and France face the longest waiting times to...

November 21, 2023 | Tuesday | Reports

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close